Targeted Cationic Liposomes, Technologies, and Developments

The author provides a brief review of tumor-specific and liver-targeted cationic liposomes and the strategies for the development of liposome-ligand complexes.

Related Content:

Drug DeliveryDevelopmentPharmaceutical Technology-12-02-2003

FDA Accepts IND for Airway Therapeutics’ Treatment for Severe COVID-19 Patients

Advanced Manufacturing Technologies Shift Outside the Box

Balancing the Art and Science of Topical Drug Formulation